Industry Articles

Informing the Drug Development and Commercialization Industry Cary, N.C. - January 31, 2012 - Industry Standard Research (ISR) today announced the release of two new reports focused on the biosimilar industry. “US Payers and Biosimilar Formulary Placement” and “Biosimilars: A…

Informing the Drug Development and Commercialization Industry Cary, N.C. - January 17, 2012 - Industry Standard Research (ISR) today announced the release of a new report focused on the impact comparative effectiveness research (CER) is and will have on formulary…

Cary, N.C. – January 11, 2012 – Industry Standard Research (ISR) today announced the availability of a new report titled "Electronic vs. In-person Detailing: A head-to-head comparison of Volume, Time, Value and Outcomes" that captures and compares product detail experiences…

Cary, N.C. - January 4, 2012 - Industry Standard Research (ISR) today announced the release of a new report titled “Clinical Imaging Market Dynamics and Service Provider Performance” in which 36 pharmaceutical sponsor decision-makers provide their usage, insights, and forecasts…

Informing the Drug Development and Commercialization Industry Cary, N.C. - December 13, 2011 - Industry Standard Research (ISR) today announced the release of a new report titled “Cardiac Safety / ECG Market Dynamics and Service Provider Performance” in which 79…

Cary, N.C. - September 19, 2011 - Industry Standard Research (ISR) today announced the release of an important piece of research, this one profiling the post-marketing safety industry. ISR's new "Post-marketing Safety Market Overview and Outlook" report provides pharmaceutical companies…

Cary, N.C. - September 13, 2011 - Industry Standard Research (ISR) today announced the release of a new report titled "Improving Adherence and Compliance: The Pharmacist’s View" in which 86 US-based retail (non-hospital based) pharmacists provided significant insights on the…

Cary, N.C. - August 16, 2011 - Industry Standard Research (ISR) today announced the release of their "2011 Phase I Market Overview and Outlook" report, in which 104 pharmaceutical decision makers responsible for Phase I activities provide valuable insight into…

Cary, N.C. - June 13, 2011 - Industry Standard Research (ISR) today announced the availability of its 3rd annual CRO Quality Benchmarking Report. The 2011 version of the report profiles 169 pharmaceutical and biotechnology professionals and their experiences with dozens…

Cary, N.C. - June 9, 2011 - Industry Standard Research (ISR) today announced the launch of a new and substantial research report titled "Domestic Chinese Pharmaceutical Companies: Competitor, Complementor, or Catalyst" This report profiles 18 of the largest and fastest-growing…

Cary, N.C. - May 17, 2011 - Industry Standard Research (ISR) today announced the launch of a new and substantial research report titled "EDC and ePRO Market Overview and Outlook." This report presents data and analysis from 107 interviews with…

Cary, N.C. - February 8, 2011 - Industry Standard Research (ISR) today announced the launch of two new and substantial research reports titled "The Future of Clinical Monitoring" and "Clinical Development Staff Quality and Resourcing Models". "It seems that every…